Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics, Inc. is listed in the United States. Sector: Healthcare. Industry: Biotechnology.

Halozyme Therapeutics, Inc. (HALO): research close 95.97 USD on 2026-11-17. 52-week range 61.63 to 131.18 USD. Historical research data, not advice.

Dated company evidence

FactFigureAs of
Historical research close95.97 USD2026-11-17
Previous research close96.50 USD2026-11-16
Change between the two dated research closes-0.55%2026-11-16 – 2026-11-17
Market capitalisation10.95 billion USD2026-11-16
52-week range of the research close61.63 – 131.18 USD2025-11-18 – 2026-11-17
One-year change in the research close36.01%2025-11-17 – 2026-11-17
Average daily turnover (20 sessions)273.97 million USD2026-11-17

Source: us_closes_adjusted · US · research close

Historical research prices; adjustments vary by market. This is not a live quote or a forecast.

Continue your company research

Members can compare available company evidence and explicitly save HALO to a watchlist. A company is saved only after Save is pressed for it.

Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.

Nine member offerings. Free. No card.

Join free

Research, not advice.

Research on this page's measures

Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate

Most-traded US companies

Full list of most-traded US companies